PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $20,352,000 | -16.5% | 1,710,265 | 0.0% | 0.43% | -33.2% |
Q2 2022 | $24,371,000 | -31.6% | 1,710,265 | 0.0% | 0.65% | -16.3% |
Q1 2022 | $35,608,000 | -9.9% | 1,710,265 | 0.0% | 0.78% | +11.5% |
Q4 2021 | $39,507,000 | -22.5% | 1,710,265 | 0.0% | 0.70% | -1.3% |
Q3 2021 | $50,966,000 | -12.8% | 1,710,265 | 0.0% | 0.71% | -24.7% |
Q2 2021 | $58,423,000 | +3.9% | 1,710,265 | 0.0% | 0.94% | +10.6% |
Q1 2021 | $56,251,000 | -46.5% | 1,710,265 | 0.0% | 0.85% | -42.4% |
Q4 2020 | $105,198,000 | +73.3% | 1,710,265 | 0.0% | 1.47% | +32.4% |
Q3 2020 | $60,714,000 | – | 1,710,265 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |